|
KMID : 0191120220370100082
|
|
Journal of Korean Medical Science
2022 Volume.37 No. 10 p.82 ~ p.82
|
|
|
A Case Report for Using Methylprednisolone for Severe ARDS Caused by SARS-CoV-2 Delta Variant in a Pediatric Patient With Lennox-Gastaut Syndrome
|
|
Park Esther
You Ji-Hye
|
|
|
Abstract
|
|
|
|
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) resulted in the coronavirus disease 2019 (COVID-19) pandemic. COVID-19 can result in fatal comorbidities, including acute respiratory distress syndrome (ARDS). Several reports suggest that children have milder illness, though severe cases have still been reported. We report a 9-year-old boy with ARDS caused by the SARS-CoV-2 delta (B.1.617.2) variant. He was admitted to our hospital and carefully observed due to underlying Lennox-Gastaut syndrome. He developed intractable seizures with a high fever. Although the seizures were controlled, his respiratory condition deteriorated to severe ARDS. High-dose methylprednisolone was administered with high positive end-expiratory pressure and low tidal volume. After ARDS treatment, oxygenation improved sufficiently to permit extubation. This case suggests that close observation is required in pediatric patients with neurologic comorbidities because of an increased risk for severe COVID-19.
|
|
|
KEYWORD
|
|
|
Coronavirus Disease-19 (COVID-19), Respiratory Distress Syndrome, Lennox-Gastaut Syndrome, Methylprednisolone
|
|
|
FullTexts / Linksout information
|
|
|
|
|
Listed journal information
|
|
    
|